These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29255041)

  • 61. Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization.
    Thornlow DN; Macintyre AN; Oguin TH; Karlsson AB; Stover EL; Lynch HE; Sempowski GD; Schmidt AG
    Front Immunol; 2021; 12():737973. PubMed ID: 34691043
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
    Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
    J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
    Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
    Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
    Magadán JG; Altman MO; Ince WL; Hickman HD; Stevens J; Chevalier A; Baker D; Wilson PC; Ahmed R; Bennink JR; Yewdell JW
    PLoS Pathog; 2014 Jun; 10(6):e1004204. PubMed ID: 24945804
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.
    Ndifon W; Wingreen NS; Levin SA
    Proc Natl Acad Sci U S A; 2009 May; 106(21):8701-6. PubMed ID: 19439657
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.
    Qian M; Hu H; Zuo T; Wang G; Zhang L; Zhou P
    J Virol; 2013 Mar; 87(6):3571-7. PubMed ID: 23269809
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination.
    Lee J; Boutz DR; Chromikova V; Joyce MG; Vollmers C; Leung K; Horton AP; DeKosky BJ; Lee CH; Lavinder JJ; Murrin EM; Chrysostomou C; Hoi KH; Tsybovsky Y; Thomas PV; Druz A; Zhang B; Zhang Y; Wang L; Kong WP; Park D; Popova LI; Dekker CL; Davis MM; Carter CE; Ross TM; Ellington AD; Wilson PC; Marcotte EM; Mascola JR; Ippolito GC; Krammer F; Quake SR; Kwong PD; Georgiou G
    Nat Med; 2016 Dec; 22(12):1456-1464. PubMed ID: 27820605
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Van Domselaar G; He R; Li X
    J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490585
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
    Yamayoshi S; Ito M; Uraki R; Sasaki T; Ikuta K; Kawaoka Y
    J Infect; 2018 Feb; 76(2):177-185. PubMed ID: 29248585
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
    Lipatov AS; Gitelman AK; Smirnov YuA
    Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.
    Krammer F; Palese P; Steel J
    Curr Top Microbiol Immunol; 2015; 386():301-21. PubMed ID: 25007847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve.
    Fu Y; Zhang Z; Sheehan J; Avnir Y; Ridenour C; Sachnik T; Sun J; Hossain MJ; Chen LM; Zhu Q; Donis RO; Marasco WA
    Nat Commun; 2016 Sep; 7():12780. PubMed ID: 27619409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.
    Bajic G; Maron MJ; Adachi Y; Onodera T; McCarthy KR; McGee CE; Sempowski GD; Takahashi Y; Kelsoe G; Kuraoka M; Schmidt AG
    Cell Host Microbe; 2019 Jun; 25(6):827-835.e6. PubMed ID: 31104946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epitope-focused vaccine design against influenza A and B viruses.
    Ren H; Zhou P
    Curr Opin Immunol; 2016 Oct; 42():83-90. PubMed ID: 27343703
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1.
    Wang P; Zuo Y; Sun J; Zuo T; Zhang S; Guo S; Shi X; Liang M; Zhou P; Zhang L; Wang X
    J Biol Chem; 2019 Mar; 294(12):4290-4303. PubMed ID: 30737282
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface.
    Zost SJ; Dong J; Gilchuk IM; Gilchuk P; Thornburg NJ; Bangaru S; Kose N; Finn JA; Bombardi R; Soto C; Chen EC; Nargi RS; Sutton RE; Irving RP; Suryadevara N; Westover JB; Carnahan RH; Turner HL; Li S; Ward AB; Crowe JE
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34156974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus.
    Zhai L; Zhang L; Jiang Y; Li B; Yang M; Victorovich KV; Aleksandrovna KT; Li M; Wang Y; Huang D; Zeng Z; Ren Z; Cao H; Zhu L; Wu Q; Xiao W; Zhang B; Wan C; Wang F; Xia N; Zhao W; Chen Y; Shen C
    J Med Virol; 2023 Jan; 95(1):e28106. PubMed ID: 36039848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.